These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12184919)

  • 21. Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis.
    Chang-hong S; Xiao-wu W; Hai Z; Ting-fen Z; Li-Mei W; Zhi-kai X
    DNA Cell Biol; 2008 Apr; 27(4):199-207. PubMed ID: 18163878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
    Fan X; Gao Q; Fu R
    Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of an effective delivery system for intranasal immunization against Mycobacterium tuberculosis ESAT-6 antigen.
    Amini Y; Tebianian M; Mosavari N; Fasihi Ramandi M; Ebrahimi SM; Najminejad H; Dabaghian M; Abdollahpour M
    Artif Cells Nanomed Biotechnol; 2017 Mar; 45(2):291-296. PubMed ID: 26924121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis.
    Dhar N; Rao V; Tyagi AK
    Med Microbiol Immunol; 2004 Feb; 193(1):19-25. PubMed ID: 12905016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant.
    Chaitra MG; Nayak R; Shaila MS
    Vaccine; 2007 Oct; 25(41):7168-76. PubMed ID: 17709160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
    Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of secretory proteins Rv3619c and Rv3620c from Mycobacterium tuberculosis H37Rv.
    Mahmood A; Srivastava S; Tripathi S; Ansari MA; Owais M; Arora A
    FEBS J; 2011 Jan; 278(2):341-53. PubMed ID: 21134129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epitope based recombinant BCG vaccine elicits specific Th1 polarized immune responses in BALB/c mice.
    Christy AJ; Dharman K; Dhandapaani G; Palaniyandi K; Gupta UD; Gupta P; Ignacimuthu S; Narayanan S
    Vaccine; 2012 Feb; 30(7):1364-70. PubMed ID: 22200502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection.
    Fonseca DM; Silva CL; Paula MO; Soares EG; Marchal G; Horn C; Bonato VL
    Immunology; 2007 Aug; 121(4):508-17. PubMed ID: 17433075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
    Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
    Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
    Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Construction, identification and immunoreactivity of Mycobacterium tuberculosis DNA vaccine pVAX1/ESAT-6 plasmid].
    Wang X; Wang Y; Xue Y; Chen Y; Tao Z; Xia H; Tang J; Fang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):945-50. PubMed ID: 23895830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
    Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a new DNA vaccine based on mycobacterial ESAT-6 antigen delivered by recombinant invasive Lactococcus lactis FnBPA+.
    Pereira VB; Saraiva TD; Souza BM; Zurita-Turk M; Azevedo MS; De Castro CP; Mancha-Agresti P; Dos Santos JS; Santos AC; Faria AM; Leclercq S; Azevedo V; Miyoshi A
    Appl Microbiol Biotechnol; 2015 Feb; 99(4):1817-26. PubMed ID: 25503506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant.
    Khademi F; Sahebkar A; Fasihi-Ramandi M; Taheri RA
    APMIS; 2018 Jun; 126(6):509-514. PubMed ID: 29924445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of responses elicited by immunization with a Legionella species common lipoprotein delivered as naked DNA or recombinant protein.
    Yoon WS; Park SH; Park YK; Park SC; Sin JI; Kim MJ
    DNA Cell Biol; 2002 Feb; 21(2):99-107. PubMed ID: 11953009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudo-rationale design of efficient TB vaccines: lesson from the mycobacterial 27-kDa lipoprotein.
    Hovav AH; Bercovier H
    Tuberculosis (Edinb); 2006; 86(3-4):225-35. PubMed ID: 16515885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.
    Wu J; Ma H; Qu Q; Zhou WJ; Luo YP; Thangaraj H; Lowrie DB; Fan XY
    Vaccine; 2011 Oct; 29(44):7624-30. PubMed ID: 21856352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel vaccine strategy to induce mycobacterial antigen-specific Th1 responses by utilizing the C-terminal domain of heat shock protein 70.
    Uto T; Tsujimura K; Uchijima M; Seto S; Nagata T; Suda T; Chida K; Nakamura H; Koide Y
    FEMS Immunol Med Microbiol; 2011 Mar; 61(2):189-96. PubMed ID: 21204994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.